Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Mylotarg (gemtuzumab ozogamicin)
pCPA File Number:
21180
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Myeloid Leukemia
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
pCODR 10190
pCPA Engagement Letter Issued:
2020-06-17
Negotiation Process Concluded:
2020-08-12